BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17213807)

  • 1. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.
    Shi Q; Bao S; Song L; Wu Q; Bigner DD; Hjelmeland AB; Rich JN
    Oncogene; 2007 Jun; 26(28):4084-94. PubMed ID: 17213807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
    Shi Q; Hjelmeland AB; Keir ST; Song L; Wickman S; Jackson D; Ohmori O; Bigner DD; Friedman HS; Rich JN
    Mol Carcinog; 2007 Jun; 46(6):488-96. PubMed ID: 17219439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival.
    McDonald PC; Oloumi A; Mills J; Dobreva I; Maidan M; Gray V; Wederell ED; Bally MB; Foster LJ; Dedhar S
    Cancer Res; 2008 Mar; 68(6):1618-24. PubMed ID: 18339839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin stimulates vascular smooth muscle cell migration by inducing FAK phosphorylation and ILK dephosphorylation.
    Li JJ; Han M; Wen JK; Li AY
    Biochem Biophys Res Commun; 2007 Apr; 356(1):13-9. PubMed ID: 17336930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin-linked kinase acts as a pro-survival factor against high glucose-associated osmotic stress in human mesangial cells.
    Ohnishi M; Hasegawa G; Yamasaki M; Obayashi H; Fukui M; Nakajima T; Ichida Y; Ohse H; Mogami S; Yoshikawa T; Nakamura N
    Nephrol Dial Transplant; 2006 Jul; 21(7):1786-93. PubMed ID: 16611685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas.
    Seno T; Harada H; Kohno S; Teraoka M; Inoue A; Ohnishi T
    Int J Oncol; 2009 Mar; 34(3):707-15. PubMed ID: 19212676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK.
    Liu DP; Wang Y; Koeffler HP; Xie D
    Int J Oncol; 2007 Apr; 30(4):865-71. PubMed ID: 17332925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in human gliomas is associated with unfavorable overall survival.
    Ding L; Sun X; You Y; Liu N; Fu Z
    Transl Res; 2010 Jul; 156(1):45-52. PubMed ID: 20621036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal adhesion kinase promotes the aggressive melanoma phenotype.
    Hess AR; Postovit LM; Margaryan NV; Seftor EA; Schneider GB; Seftor RE; Nickoloff BJ; Hendrix MJ
    Cancer Res; 2005 Nov; 65(21):9851-60. PubMed ID: 16267008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells.
    Rosenzweig T; Ziv-Av A; Xiang C; Lu W; Cazacu S; Taler D; Miller CG; Reich R; Shoshan Y; Anikster Y; Kazimirsky G; Sarid R; Brodie C
    Cancer Res; 2006 Apr; 66(8):4139-48. PubMed ID: 16618735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes.
    Laczko R; Szauter KM; Jansen MK; Hollosi P; Muranyi M; Molnar J; Fong KS; Hinek A; Csiszar K
    Neuropathol Appl Neurobiol; 2007 Dec; 33(6):631-43. PubMed ID: 17931358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase.
    Tsutsumi K; Kasaoka T; Park HM; Nishiyama H; Nakajima M; Honda T
    Int J Oncol; 2008 Jul; 33(1):215-24. PubMed ID: 18575768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of focal adhesion kinase by small interfering RNAs reduces chondrocyte redifferentiation capacity in alginate beads culture with type II collagen.
    Kim YH; Lee JW
    J Cell Physiol; 2009 Mar; 218(3):623-30. PubMed ID: 19006177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-FLIP promotes the motility of cancer cells by activating FAK and ERK, and increasing MMP-9 expression.
    Park D; Shim E; Kim Y; Kim YM; Lee H; Choe J; Kang D; Lee YS; Jeoung D
    Mol Cells; 2008 Apr; 25(2):184-95. PubMed ID: 18414015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK.
    Kamarajan P; Kapila YL
    Apoptosis; 2007 Dec; 12(12):2221-31. PubMed ID: 17879163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibronectin promotes invasiveness and focal adhesion kinase tyrosine phosphorylation of human colon cancer cell.
    Ding J; Li D; Wang X; Wang C; Wu T
    Hepatogastroenterology; 2008; 55(88):2072-6. PubMed ID: 19260479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin-linked kinase activity is associated with interleukin-1 alpha-induced progressive behavior of pancreatic cancer and poor patient survival.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    Oncogene; 2006 Jun; 25(23):3237-46. PubMed ID: 16407822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1.
    Zheng Y; Ritzenthaler JD; Sun X; Roman J; Han S
    Cancer Res; 2009 Feb; 69(3):896-904. PubMed ID: 19176380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ephrin-B3 ligand promotes glioma invasion through activation of Rac1.
    Nakada M; Drake KL; Nakada S; Niska JA; Berens ME
    Cancer Res; 2006 Sep; 66(17):8492-500. PubMed ID: 16951161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation.
    Shi Q; Bao S; Maxwell JA; Reese ED; Friedman HS; Bigner DD; Wang XF; Rich JN
    J Biol Chem; 2004 Dec; 279(50):52200-9. PubMed ID: 15469933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.